ASCO 2017

ASCO 2017 Poster Report of Apatinib Phase III Trial in Progress

This poster presents the on-going global phase 3 trial of apatinib (ANGEL study) that investigates its efficacy and safety in previously treated advanced gastric cancer patients in North America, Europe, and Asia Pacific (outside of China). This ‘Trials in Progress’ poster highlighted the clinical trial design, objectives, major eligibility criteria, and statistical methods of the trial, and was presented on June 3rd at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. For more information on the ANGEL study, please visit the page.

To read the full report, download the poster.